Evidence map›Paper›PMID 34648386›Full record

ReviewJCO global oncology2021

Cancer Survivorship in Latin America: Current Status and Opportunities.

Andrea Anampa-Guzmán, Francisco Acevedo, Ann H Partridge, Catherine M Alfano, Larissa Nekhlyudov

Abstract readReview
In one paragraph

Review in JCO global oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Oncology Education in Latin America: A Systematic Review of Curricular Gaps, Teaching Strategies, and Regional Initiatives.Journal of cancer education : the official journal of the American Association for Cancer Education · 2025
    Review
  3. Article
  4. Article
  5. Observational
  6. Importance of an Oncology Interest Group in Medical School: Experience from a Developing Country.Journal of cancer education : the official journal of the American Association for Cancer Education · 2025
    Review
  7. Review
  8. Review
  9. Review
  10. Observational
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Andrea Anampa-GuzmánSan Fernando Medical School, Faculty of Medicine, Universidad Nacional Mayor de San Marcos, Lima, Peru.ORCID 0000-0002-4292-1137
Francisco AcevedoDepartment of Hematology and Oncology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
Ann H PartridgeDepartment of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.ORCID 0000-0002-4722-4824
Catherine M AlfanoNorthwell Health Cancer Institute, Center for Personalized Health, New York, NY.ORCID 0000-0001-6488-2186
Larissa NekhlyudovDepartment of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.ORCID 0000-0001-6747-4209

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe number of cancer survivors is increasing globally although the status of cancer survivorship care provision and research in developing countries is limited. This study aimed to review published literature and available guidelines and/or recommendations to inform cancer survivorship care in Latin America.

methodsEmbase, Web of Science, Scopus, PubMed, and SciELO were systematically searched for articles and guidelines and/or recommendations published through December 31, 2020. Our search terms included cancer, survivors, neoplasm, cancer, survivorship, survivor, follow-up studies, and the name of the countries. We categorized the articles by country, year, cancer type(s), language, and domain of cancer survivorship care. We also searched governmental health agencies websites in all Latin American countries.

resultsOur literature review found 664 articles for inclusion. The number of publications increased over time. Brazil had most of the survivorship research (n = 483, 72.7%). The most common topics included surveillance and management of psychosocial effects (n = 237, 35.7%) and physical effects (n = 230, 34.6%). Prevention and surveillance for recurrences and health promotion and disease prevention were each addressed by about 10% (n = 71) of the publications. Although close to half of the publications included more than one cancer, 28.9% (n = 192) focused solely on breast cancer. We found no guidelines and/or recommendations explicitly focusing on Latin America in the reviews of the literature or the national governmental institutions' websites.

conclusionWe found a growing body of cancer survivorship publications, mainly focusing on psychosocial and physical effects, although no cancer survivorship guidance and/or recommendations focused on Latin America were identified. Expanding research across Latin American countries and covering a broader spectrum of cancer survivorship care is needed. Development of guidelines may further promote provision of quality care for this growing population of cancer survivors.

Indexed as

Cancer SurvivorsSurvivorshipHumansLatin AmericaNeoplasm Recurrence, LocalSurvivors

Identifiers

PMID34648386
PMCPMC8791813

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.